Dr. Brooke Chandrasoma, M.D

NPI: 1770785610
Total Payments
$8,101
2024 Payments
$176.00
Companies
38
Transactions
406
Medicare Patients
5,947
Medicare Billing
$1.1M

Payment Breakdown by Category

Food & Beverage$7,636 (94.3%)
Travel$420.00 (5.2%)
Education$44.38 (0.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,636 402 94.3%
Travel and Lodging $420.00 2 5.2%
Education $44.38 2 0.5%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $2,264 145 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $900.21 38 $0 (2023)
Philips Electronics North America Corporation $556.21 24 $0 (2020)
Sunovion Pharmaceuticals Inc. $519.12 32 $0 (2019)
AstraZeneca Pharmaceuticals LP $502.62 24 $0 (2020)
Olympus Corporation of the Americas $452.03 5 $0 (2017)
ADVANCED RESPIRATORY, INC $314.68 8 $0 (2019)
Mylan Specialty L.P. $282.17 17 $0 (2024)
Grifols USA, LLC $260.64 11 $0 (2020)
PORTOLA PHARMACEUTICALS, INC. $156.59 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $176.00 8 GlaxoSmithKline, LLC. ($133.57)
2023 $224.94 12 GlaxoSmithKline, LLC. ($198.22)
2022 $487.68 15 GlaxoSmithKline, LLC. ($164.71)
2021 $318.21 18 GlaxoSmithKline, LLC. ($230.37)
2020 $620.21 35 GlaxoSmithKline, LLC. ($302.46)
2019 $2,042 103 GlaxoSmithKline, LLC. ($436.81)
2018 $2,055 103 GlaxoSmithKline, LLC. ($384.12)
2017 $2,177 112 Olympus Corporation of the Americas ($452.03)

All Payment Transactions

406 individual payment records from CMS Open Payments — Page 1 of 17

Date Company Product Nature Form Amount Type
08/27/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $21.62 General
Category: RESPIRATORY
08/20/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $20.00 General
Category: Otolaryngology (Ear, Nose, Throat)
07/16/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $21.63 General
Category: RESPIRATORY
06/11/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $23.22 General
Category: RESPIRATORY
05/21/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $22.14 General
Category: RESPIRATORY
03/14/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $22.30 General
Category: RESPIRATORY
03/05/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $22.43 General
Category: Anticholinergics, Inhaled
01/18/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $22.66 General
Category: RESPIRATORY
12/15/2023 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $3.71 General
Category: IMMUNOLOGY
11/06/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $20.57 General
Category: RESPIRATORY
09/27/2023 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $19.72 General
Category: IMMUNOLOGY
09/22/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $23.68 General
Category: RESPIRATORY
08/01/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.23 General
Category: RESPIRATORY
07/27/2023 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $19.42 General
Category: IMMUNOLOGY
06/21/2023 Boehringer Ingelheim Pharmaceuticals, Inc. STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT Food and Beverage In-kind items and services $26.72 General
Category: RESPIRATORY
06/20/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $21.71 General
Category: RESPIRATORY
05/05/2023 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $5.09 General
Category: IMMUNOLOGY
04/18/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), SHINGRIX Food and Beverage In-kind items and services $22.46 General
Category: RESPIRATORY
02/06/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), NUCALA Food and Beverage In-kind items and services $21.97 General
Category: RESPIRATORY
01/17/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $23.66 General
Category: RESPIRATORY
12/13/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.50 General
Category: RESPIRATORY
11/15/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.97 General
Category: RESPIRATORY
11/09/2022 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $125.00 General
10/26/2022 Teleflex LLC UROLIFT (Device) Food and Beverage In-kind items and services $119.32 General
Category: Interventional Urology
10/04/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $18.51 General
Category: RESPIRATORY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 1,477 2,791 $517,703 $263,291
2022 15 1,600 2,938 $590,407 $279,937
2021 15 1,417 2,574 $555,039 $265,928
2020 12 1,453 3,098 $692,156 $334,823
Total Patients
5,947
Total Services
11,401
Medicare Billing
$1.1M
Procedure Codes
54

All Medicare Procedures & Services

54 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 166 420 $182,280 $72,379 39.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 326 699 $119,499 $71,185 59.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 241 673 $108,285 $66,000 61.0%
94375 Test to measure rate of airflow Office 2023 260 481 $32,066 $15,525 48.4%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 72 75 $23,273 $10,291 44.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 75 75 $19,700 $9,822 49.9%
94729 Test to examine how well the lungs exchange gases Office 2023 73 76 $7,068 $3,830 54.2%
94726 Test to determine lung volumes using sensors Office 2023 73 76 $4,812 $3,741 77.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 62 78 $5,460 $3,467 63.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 33 36 $4,176 $2,784 66.7%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Office 2023 70 73 $7,884 $2,386 30.3%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 26 29 $3,199 $1,881 58.8%
99291 Critical care, first 30-74 minutes Facility 2022 199 548 $237,832 $97,204 40.9%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 302 893 $143,773 $77,126 53.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 279 538 $91,998 $54,696 59.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 88 90 $28,080 $14,446 51.4%
94375 Test to measure rate of airflow Office 2022 203 306 $20,502 $10,110 49.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 60 60 $15,720 $7,888 50.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 70 84 $9,744 $5,879 60.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 48 53 $3,710 $2,446 65.9%
94729 Test to examine how well the lungs exchange gases Office 2022 90 95 $8,835 $2,092 23.7%
94726 Test to determine lung volumes using sensors Office 2022 90 95 $5,700 $2,037 35.7%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Office 2022 93 98 $10,584 $1,686 15.9%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 27 27 $3,051 $1,656 54.3%
36556 Insertion of non-tunneled central venous tube for infusion (5 years or older) Facility 2022 18 18 $7,218 $1,273 17.6%

About Dr. Brooke Chandrasoma, M.D

Dr. Brooke Chandrasoma, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770785610.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brooke Chandrasoma, M.D has received a total of $8,101 in payments from pharmaceutical and medical device companies, with $176.00 received in 2024. These payments were reported across 406 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($7,636).

As a Medicare-enrolled provider, Chandrasoma has provided services to 5,947 Medicare beneficiaries, totaling 11,401 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Critical Care Medicine, Pulmonary Disease
  • Location Pasadena, CA
  • Active Since 06/04/2007
  • Last Updated 06/26/2020
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1770785610

Products in Payments

  • TRELEGY ELLIPTA (Drug) $900.22
  • NUCALA (Biological) $536.58
  • ANORO (Drug) $486.81
  • EVIS EXERA (Device) $452.03
  • STIOLTO RESPIMAT (Drug) $438.90
  • inCourage (Device) $308.07
  • BROVANA (Drug) $268.16
  • BREO (Drug) $236.74
  • The Vest System Model 105 Home Care (Device) $230.24
  • ELIQUIS (Drug) $217.75
  • STIOLTO (Drug) $206.76
  • SYMBICORT (Drug) $197.42
  • Prolastin-C Liquid (Biological) $168.57
  • TUDORZA PRESSAIR (Drug) $150.85
  • ZERBAXA (Drug) $134.22
  • Dymista (Drug) $133.23
  • FASENRA (Drug) $127.02
  • Yupelri (Drug) $126.51
  • BEVYXXA (Drug) $124.49
  • UROLIFT (Device) $119.32

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Pasadena